Catherine EckfordJournalist

European Pharmaceutical Review

Health & social care coverage read by Vital Signs

5 articles

Across 4 topics, first on 30 Jan 2026, most recently 11 Sept 2026.

This counts only pieces our coverage scan read on the topics Vital Signs tracks, not their full output.

What they cover

Who they quote

Voices credited in their pieces. A reporter who has called someone before is likely to call them again.

Recent articles

  1. MHRA set to overhaul the UK’s rare disease drug regulatory pathway

    European Pharmaceutical ReviewRare diseases

  2. Strengthening female participation in clinical trials with AI-driven eConsent

    European Pharmaceutical ReviewMedical ethics & regulation11 Sept 2026

  3. Novo Nordisk’s Awiqli first FDA-approved once-weekly basal insulin

    European Pharmaceutical ReviewDiabetes27 Mar 2026

  4. GSK’s Nucala green lit for COPD in expanded EU approval

    European Pharmaceutical ReviewRespiratory (asthma/COPD)6 Feb 2026

  5. Moderna and Recordati collaborate on rare disease mRNA therapy

    European Pharmaceutical ReviewRare diseases30 Jan 2026

Bylines and quoted sources are read automatically from UK coverage of the topics Vital Signs tracks, so this page reflects what our scan has read rather than a complete record. Where a biography and photograph appear, they are published by the outlet itself about its own correspondent, and linked above. Social accounts are not held: asserting an unverified one would attach a real person to an account that might not be theirs. See the methodology, or email contact@bridgeheadcommunications.com to correct anything on it.